Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: A pilot study

British Journal of Radiology

Volumn 82, Issue 984, 2009, Pages 989-994

  Okuma, Tomohisa ^a   Matsuoka, T ^a   Yamamoto, A ^a   Hamamoto, S ^a   Nakamura, K ^a   Inoue, Y ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LUNG TUMOR; MALE; MEDICAL ETHICS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; CATHETER ABLATION; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 71549128995     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/13217618     Document Type: Article

References (25)

1. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000;174:57-59
2. de Baere T, Palussiere J, Auperin A, Hakime A, Abdel-Rehim M, Kind M, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006;240:587-596 (Pubitemid 44098659)
3. Akeboshi M, Yamakado K, Nakatsuka A, Hataji O, Taguchi O, Takao M, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004;15:463-470 (Pubitemid 38590870)
4. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinant for survival. Ann Surg Oncol 2006;13:1529-1537 (Pubitemid 44749666)
5. Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007;243: 268-275 (Pubitemid 46579719)
6. Steinke K, King J, Glenn D, Morris DL. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003;27:750-757 (Pubitemid 37087744)
7. Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 2005;185:466-471
8. Lee JM, Jin GY, Goldberg SN, Chung GH, Han YM, Lee SY, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004;230:125-134
9. Okuma T, Okamura T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 2005;20:115-121
10. Higaki F, Okumura Y, Sato S, Hiraki T, Gobara H, Mimura H, et al. Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor. Ann Nucl Med 2008;22:157-163 (Pubitemid 351729622)
11. Mardor Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 2003;21:1094-1100 (Pubitemid 46594139)
12. Tomura N, Narita K, Izumi J, Suzuki A, Anbai A, Otani T, et al. Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: possible prediction of treatment response. J Comput Assist Tomogr 2006;30:496-500. (Pubitemid 43922271)
13. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999;1:113-117
14. Uhl M, Saueressig U, Buiren M, Kontny U, Niemeyer C, Kohler G, et al. Preliminary results of In vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol 2006;41:618-623 (Pubitemid 44284169)
15. Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, et al. Monitoring therapeutic response of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 2006;16:2637-2643 (Pubitemid 44823917)
16. Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2006;17:505-512 (Pubitemid 44318722)
17. Deng J, Miller FH, Rhee TK, Sato KT, Mulcahy MF, Kulik LM, et al. Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to Yttrium-90 radioembolization. J Vasc Interv Radiol 2006;17:1195-1200 (Pubitemid 44318703)
18. Nakajima T, Endo K. FDG-PET and diffusion-weighted MR imaging. Jap J Magn Reson Med 2005;25:255-268
19. Ohira T, Okuma T, Matsuoka T, Wada Y, Nakamura K, Watanabe Y, et al. FDG-microPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits. Cardiovasc Interv Radiol 2009;32:114-120
20. Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Nakamura K, et al. Frequency and risk factors of various complication after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Interv Radiol 2008;31:122-130
21. Oyama Y, Nakamura K, Matsuoka T, Toyoshima M, Yamamoto A, Okuma T, et al. Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology. Cardiovasc Intervent Radiol 2005;28:346-353 (Pubitemid 40880755)
22. Roth Y, Tichler T, Kostenich G, Ruiz-Cabello J, Maiser SE, Cohen JS, et al. High-b-value diffusion-weighted MR imaging for pretreatment predication and early monitoring of tumor response to therapy in mice. Radiology 2004;232:685-692 (Pubitemid 39100249)
23. Geschwind JF, Artemov D, Abraham S, Omdal D, Huncharek MS, McGee C, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighed MR imaging and histologic analysis. J Vasc Interv Radiol 2000;11:1245-1255
24. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997;3:1457-1466
25. Youn BJ, Chung JW, Son KR, Kim HC, Jae HJ, Lee JM, et al. Diffusion-weighed MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit tumor. Acad Radiol 2008;15:593-600.